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To determine the presence of European bat lyssavirus 
type 1 in southern Spain, we studied 19 colonies of sero-
tine bats (Eptesicus isabellinus), its main reservoir, during 
1998–2003. Viral genome and antibodies were detected in 
healthy bats, which suggests subclinical infection. The dif-
ferent temporal patterns of circulation found in each colony 
indicate independent endemic circulation.
T
he serotine bat (Eptesicus serotinus) is considered 
the main reservoir for European bat lyssavirus type 1 
(EBLV1). Recently, southern Iberian populations of this 
species have been classiﬁ  ed as E. isabellinus (1), a bat spe-
cies previously known to exist only in North Africa.
In 1989, 5 EBLV1-infected serotine bats were found 
dead during a survey of natural colonies in Huelva (An-
dalusia). The prevalence of EBLV1 antibodies was up to 
20% among completely healthy bats that were recaptured 1 
year later, providing the ﬁ  rst direct evidence of the survival 
of serotine bats after EBLV1 infection (2). Furthermore, 
high seroprevalence and presence of viral RNA in the oral 
cavity and bloodstream of different lyssavirus species have 
been reported in healthy bats captured in natural colonies 
in which the numbers of deaths have not increased (3–5), 
showing direct evidence of subclinical or asymptomatic 
disease after viral infection. Even viral RNA and antigens 
have been detected in the brains of healthy captive bats (6). 
However, reports of experimental lyssavirus transmission 
have drawn discrepant conclusions (7–9).
The Study
During 1998–2003, a total of 1,030 E. isabellinus from 
19 colonies located in the provinces of Huelva, Seville, and 
Granada (Andalusia), in southern Spain, were sampled. We 
focused on this region because all EBLV1 cases reported in 
Spain were from southern Spain. Distances between colo-
nies varied from 0.5 to 317 km.
Bats were captured mainly in so-called maternity colo-
nies made up of adult females and young of both sexes. 
Each animal was banded and assessed for sex, age, size, 
and weight. A total of 150 (14.5%) were recaptured. The 
frequency of repeated captures reached 22.7% in individual 
bats from 3 colonies that were sampled in all 6 years of the 
study. All recaptured bats were always found in the same 
colony in which they were ﬁ  rst marked.
Viral RNA was detected in 34 (2.8%) of 1,226 oropha-
ryngeal swab specimens from 33 bats of 8 colonies (1 bat 
was resampled after a 1-week interval). One bat that tested 
positive was recaptured and tested negative in a followup 
sampling effort. Positive results were identiﬁ  ed as EBLV1 
by direct sequencing as previously described (4,10). Sam-
ples for reverse transcription–PCR were stored in a buf-
fer that was designed for RNA preservation but was not 
suitable for keeping the virus viable for isolation on cell 
culture.
A total of 626 plasma samples were tested for EBLV1-
speciﬁ  c antibodies by using a modiﬁ  cation of the rapid ﬂ  u-
orescent focus inhibition test (11), but 77 (12.3%) of them 
were found to be toxic to cells. EBLV1 antibodies were 
found in 51 (9.3%) of the remaining 549 from 13 colonies. 
Only 2 of 22 samples showing viral RNA in the oral cavity 
were antibody positive (Table). Thirteen antibody-positive 
bats were recaptured in a healthy condition in the following 
campaigns.
The temporal pattern of circulation was completely 
different in each colony (online Appendix Table, available 
from www.cdc.gov/EID/content/14/8/12653-appT.htm). 
Only 1 colony showed continuous circulation from 1998 
through 2002.
Brains were obtained from 20 bats of the same colony 
that had been studied previously (4). Differences in body 
condition between noninfected bats, bats with positive 
oropharyngeal swabs only, and bats with positive oropha-
ryngeal and brain specimens were tested by an analysis 
of variance; index of body condition was the dependent 
variable. Individual body condition was expressed as the 
residuals from an analysis of covariance with an opti-
mized design, including body mass as dependent variable; 
forearm length as a covariate; and sex, age, and year as 
ﬁ  xed factors. We found a signiﬁ  cant negative association 
(Figure 1) between RNA presence and body condition 
(F = 11.78; degrees of freedom = 2, 281; p<0.001, n = 292). 
Post hoc tests indicated that only bats whose brains tested 
  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 14, No. 8, August 2008  1263 
*Instituto de Salud Carlos III, Majadahonda, Madrid, Spain; †Cen-
tro de Investigación Biomédica en Red de Epidemiología y Salud 
Pública (CIBERESP), Spain; ‡Estación Biológica de Doñana CSIC, 
Sevilla. Spain; and §Laboratorio Central de Veterinaria de Santa 
Fe, Granada, Spain 
DOI: 10.3201/1408.080068positive had a signiﬁ  cantly worse body condition (Tukey 
honestly signiﬁ  cant differences [HSD] test  –2.33, p<0.001, 
and HSD –2.27, p<0.001, respectively). Differences in 
body condition between oropharyngeal swab–negative 
and oropharyngeal swab–positive bats were not signiﬁ  cant 
(Tukey HSD 0.57, p = 0.99).
Brain, cerebellum, and spinal cord from 1 bat carcass 
with natural EBLV1 infection were studied by histopatho-
logic and histochemical techniques. The bat was captured 
while ﬂ  ying but died during manipulation, which is an ex-
tremely rare event. The brain and oropharyngeal swab were 
positive for EBLV1 by reverse transcription–PCR, and the 
brain smear was also positive by immunoﬂ  uorescence. His-
topathologic studies showed moderate neuronal degeneration 
characterized by neuronal hyperchromatosis, chromatolysis, 
and satellitosis (Figure 2, panel A). The Sellers stain results 
were negative, proving the absence of Negri bodies (Figure 
2, panel B). The occasional presence of basophilic intracyto-
plasmic structures in neurons located in the cerebral cortex 
that underwent necrobiosis was interpreted as a neurophagic 
process that was taking place in the glial cells because these 
inclusions were shown to be positive by the Feulgen reaction 
(Figure 2, panel C), whereas the Negri bodies have a strong-
ly acidophilic nature. Moderate gliosis without perivascular 
inﬁ  ltration was observed (Figure 2, panel 2D).
Conclusions
Despite the fact that serotine bats (E. serotinus and 
E. isabellinus) are the most frequently involved species in 
cases of bat lyssavirus exposure in humans in Europe, most 
published surveys of EBLV1 infection in natural bat colo-
nies have focused on other bat species (5,12). Data from 
serotine bats have been obtained by either serologic or di-
rect detection techniques but not from both (2,4), as in this 
report.
Our recapture data show an absence of switching 
among colonies, even between colonies located only a few 
kilometers apart. This result indicates highly philopatric 
behavior among female bats, as has been conﬁ  rmed in a 
recent mtDNA-based study of these colonies (J. Juste, un-
pub. data). This could be the cause of the different tem-
poral distribution of the positive results observed in each 
colony, which suggests a pattern of independent endemic 
viral circulation different from the model, based on peri-
odic epidemic waves of fast viral spreading proposed for 
the mouse-eared bat (Myotis myotis) (12).
The analysis of body condition index as a measure 
of physiologic condition gives additional evidence for 
mild or subclinical infection in the previously described 
long-term survival of EBLV1 RNA or antibody-positive 
bats (2,4,5,12). Similar body condition values between 
bats with oropharyngeal swabs that were positive for the 
virus and those that were negative could be interpreted 
as a recent virus infection for which no symptoms have 
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Table. European bat lyssavirus type 1 in Eptesicus isabellinus 
bats, Spain, 1999–2003* 
Type of testing  RT-PCR RFFIT
Total captures 1,226 626
No. colonies 19 13
Total no. (%) positive 34 (2.8) 51 (9.3)
1998
 No.  captures 164 151
  No.  (%) positive 4 (2.4) 10 (6.6)
1999
  No. (%) captures 161 90
  No. positive  4 (2.5) 5 (5.6)
2000
 No.  captures 204 128
  No. (%) positive 16 (7.8) 12 (9.4)
2001
 No.  captures  209 96
 No.  positive 0 4  (4.2%)
2002
 No.  captures 287 100
  No. (%) positive 10 (3.4) 5 (5.0)
2003
 No.  captures 201 54
 No.  positive 0 0
*Results obtained during active surveillance. RT-PCR, reverse 
transcription–PCR, RFFIT, rapid fluorescent focus inhibition test. 
Figure 1. Relationship between body condition index (mean ± 
standard error) and diagnosis of European bat lyssavirus type 1 
by reverse transcription PCR. Males and females are represented 
as  ﬁ   lled and open circles, respectively. 1, only negative in oro-
pharyngeal swab and brain specimens (z n = 49; c n = 225); 
2, positive in oropharyngeal swab and brain specimens (z n = 1; 
c n = 4); 3, positive in oropharyngeal swab but negative in brain 
specimen (z n = 3; c n = 4).European Bat Lyssavirus, Spain
developed. However, 1 lyssavirus-positive bat showed no 
viral RNA 3 years later. One bat even showed RNA in the 
oral cavity in consecutive samples separated by 1 week. 
Our ﬁ  ndings suggest that asymptomatic EBLV1 RNA car-
riage may be common in serotine bats (2–5,9,13,14). In 
only a small subset of them does symptomatic neurologic 
infection progress to more severe body condition. How-
ever, most of these bats were captured while they were ﬂ  y-
ing, and only 1 of those involved in an episode of human 
exposure had lost the ability to ﬂ  y. This bat had the poorest 
body condition. The absence of Negri bodies and the mod-
erate percentage of nerve cells affected found in the bat, 
captured while ﬂ  ying, suggest a subclinical process, as has 
been proposed for EBLV1 in Rousettus aegyptiacus (6,14). 
We cannot predict whether severe encephalitis was about to 
develop in these bats. The lack of pathogenicity could have 
arisen through long-standing coevolution between bats and 
viruses, as the phylogenetic data suggest (15). Neverthe-
less, additional work is necessary to establish whether the 
presence of EBLV1 RNA in the oral cavity is associated 
with the excretion of live virus.
In a similar study of M. daubentonii in the United 
Kingdom, only EBLV2 antibodies, but not viral RNA in 
the oropharyngeal cavity, were reported (3). Another study 
of the experimental transmission of Aravan, Khujand, and 
Irkut viruses to E. fuscus found oral excretion only in bats 
whose conditions were progressing to neurologic infec-
tion and death (8). These facts suggest differences between 
models of pathogenesis of lyssavirus infections in bats.
In summary, our ﬁ  ndings indicate that natural mater-
nity colonies of E. isabellinus behave as close communities 
in which EBLV1 independently circulates, which suggests 
an endemic pattern associated with asymptomatic or mild 
disease. Further studies are needed to 1) investigate the 
circumstances under which neurologic manifestations de-
velop in bats (which lead to the abnormal behavior usually 
associated with human exposures) and 2) to establish the 
epidemiologic implications for public health of asymptom-
atic oral RNA carriage. The anthropophilic behavior of this 
bat species makes active surveillance highly recommended 
to predict risk factors that allow taking political decisions 
relating to public health.
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Figure 2. Pathologic images obtained from a carcass of Eptesicus isabellinus. The bat was captured while ﬂ   ying but died during 
handling. Brain specimen was positive for lyssavirus antigens by immunoﬂ  uorescence and for European bat lyssavirus 1 RNA by reverse 
transcription–PCR. A) Neural degeneration in brain by hematoxylin and eosin stain (H&E); magniﬁ  cation ×400. B) Negative Seller stain 
in spinal cord indicating the absence of Negri bodies; magniﬁ  cation ×400. C) Positive Feulgen reaction in brain, glial cell neurophagia; 
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